FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

175 letters match. Newest first.

  1. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk
  2. Ng Zheng Inc. DBA Kwan Sang Noodle Company

    FDA warns Denver noodle maker over allergen, pathogen, pest and sanitation failures and missing food facility registration.

    High risk
  3. Westwood Laboratories LLC

    FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.

    High risk
  4. Vintage Chemical Inc.

    FDA warned Vintage Chemical after an inspection found over-the-counter hand soap and sanitizer made on equipment shared with industrial cleaners.

    High risk
  5. Pingdingshan Tianjing Plant Albumen Co., Ltd.

    FDA cited Pingdingshan Tianjing Plant Albumen, a Chinese maker of ready-to-eat soy protein isolate, for insanitary conditions and unsupported test results on certificates.

    High risk
  6. Betone S.A. de C.V.

    FDA warns Betone S.A. de C.V. over manufacturing violations for OTC antiseptic wipes, including subpotent active and missing glycerin safety tests.

    High risk
  7. Deqing Jiarou Daily Chemical Co., Ltd.

    Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.

    High risk
  8. Colgin, Inc.

    FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.

    High risk
  9. Les Importations Herbasanté Inc.

    Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.

    High risk
  10. Glicerinas Industriales, S.A. de C.V.

    FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.

    High risk
  11. Woorilife & Health

    Woorilife & Health, a South Korean OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  12. Patcos Cosmetics Pvt. Ltd.

    Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  13. Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi

    FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.

    High risk
  14. Cerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi

    FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.

    High risk
  15. Xiamen Wally Bath Manufacture Co., Ltd.

    FDA warns Xiamen Wally Bath over current good manufacturing practice failures for over-the-counter hand sanitizer, including raw material and release testing gaps.

    High risk
  16. National Chemical Laboratories

    National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.

    High risk
  17. InnoMark, Inc.

    FDA warned InnoMark, Inc. about dietary supplements made under poor manufacturing conditions and with misleading labels after a March 2023 inspection.

    High risk
  18. Handock Cosmetics Co., Ltd.

    FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.

    High risk
  19. Kor-Chem, Inc.

    Kor-Chem, Inc. made OTC hand sanitizer drugs with manufacturing violations, including shared equipment with industrial chemicals and missing identity and microbial testing.

    High risk
  20. Gadal Laboratories Inc.

    FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.

    High risk
  21. International Laboratories Corp. Ltd.

    International Laboratories Corp. Ltd. failed manufacturing-practice rules for OTC drugs, including component identity testing and quality-unit oversight.

    High risk
  22. STPCA Inc. dba Sun Ten Laboratories

    FDA: Sun Ten Laboratories sold herbal products as unapproved drugs and broke supplement manufacturing rules at its Irvine, California plant.

    High risk
  23. Fancystage Unipessoal, LDA

    Portugal OTC drug maker Fancystage Unipessoal skipped identity testing of high-risk ingredients and lacked quality-unit control, FDA says.

    High risk
  24. Avlon Industries, Inc.

    FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.

    High risk
  25. LXR Biotech, LLC

    FDA says LXR Biotech, a contract maker of an OTC drug, shipped batches without testing components or finished product.

    High risk
  26. Fuller Industries Inc.

    FDA warns Fuller Industries over current good manufacturing practice violations in OTC hand soaps and sanitizers, including quality oversight and ingredient testing.

    High risk
  27. Brand Packaging Group, Inc.

    Brand Packaging Group, a Farmingdale, NY dietary supplement maker, failed to test finished batches and ingredient identity, FDA found.

    High risk
  28. Mr. Lulu LLC

    FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.

    High risk
  29. Sure-Biochem Laboratories, LLC

    FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.

    High risk
  30. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  31. Drivergent, Inc.

    Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.

    High risk
  32. Chemical Services Group, Inc./Royal Chemical Company

    Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.

    High risk
  33. Omega Packaging Corp

    Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.

    High risk
  34. NuGeneration Technologies LLC

    FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.

    High risk
  35. Cosmetic Science Laboratories LLC

    FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.

    High risk
  36. Dunagin Pharmaceuticals Inc. dba Massco Dental

    Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.

    High risk
  37. Formology Lab Inc.

    FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.

    High risk
  38. Skyless, LLC

    FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.

    High risk
  39. Ultra Chem Labs Corporation

    FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.

    High risk
  40. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

    FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.

    High risk
  41. Clean Cosmetics LLC

    FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.

    High risk
  42. Fei Fah Medical Manufacturing Pte. Ltd.

    FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.

    High risk
  43. Superior Glove Works, Ltd.

    Canada's Superior Glove Works made hand sanitizers with ethanol containing unsafe acetaldehyde levels and skipped required testing, FDA says.

    High risk
  44. Big Olaf Creamery LLC dba Big Olaf

    Big Olaf Creamery's ready-to-eat ice cream was tied to a 28-case Listeria outbreak and made under insanitary conditions.

    High risk
  45. MD Pharmaceutical Supply, LLC

    FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.

    High risk
  46. DuPont Nutrition USA Inc.

    FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.

    High risk
  47. Kari Gran Inc.

    Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.

    High risk
  48. The Ben Heggy Candy Company

    FDA warned Ben Heggy Candy Company that its ready-to-eat chocolates were made under insanitary conditions and mislabeled.

    High risk
  49. Omega & Delta Co., Inc.

    FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.

    High risk
  50. McConnell Labs Inc.

    McConnell Labs Inc. released hand sanitizers without raw material identity, finished product, or stability testing, FDA says.

    High risk